Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.1%. By the end of trading, Isis Pharmaceuticals rose $2.42 (6.7%) to $38.48 on heavy volume. Throughout the day, 4,111,752 shares of Isis Pharmaceuticals exchanged hands as compared to its average daily volume of 1,641,400 shares. The stock ranged in a price between $37.12-$39.83 after having opened the day at $37.27 as compared to the previous trading day's close of $36.06. Other companies within the Health Care sector that increased today were:
), up 64.3%,
), up 35.4%,
), up 33.9% and
), up 28.2%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. Isis Pharmaceuticals has a market cap of $4.2 billion and is part of the drugs industry. Shares are up 247.4% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Isis Pharmaceuticals a buy, 2 analysts rate it a sell, and 1 rates it a hold.
TheStreet Ratings rates Isis Pharmaceuticals as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive.
- You can view the full Isis Pharmaceuticals Ratings Report.
On the negative front,
), down 11.7%,
), down 11.4%,
), down 10.9% and
), down 10.6% , were all laggards within the health care sector with
) being today's health care sector laggard.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.